Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00231478Phase 4Completed
Phase 4, randomised, double-blind trial of granisetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Roche. Primary endpoint: Number of Patients With no Vomiting. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00231478.